Quetiapine Augmentation in Severe Obsessive Compulsive Disorder

Clinical trial NCT00254735 · COMPLETED

Trial details

NCT number: NCT00254735
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Obsessive Compulsive Disorder

Start date: 2002-04-01
Enrollment: 44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.